The Association between COVID-19 and Changes in Opioid Prescribing Patterns and Opioid-Related Overdoses: A Retrospective Cohort Study.  Robins A, Dimitriev A, MacKay C, Wang H, Kearney A, Borschneck DP, Simpson A.  Can J Pain. 2023 Apr…

Impact of COVID-19 pandemic on chronic pain and opioid use in marginalized populations: A scoping review.  Choe K, Zinn E, Lu K, Hoang D, Yang LH.  Front Public Health. 2023 Apr 17;11:1046683. doi: 10.3389/fpubh.2023.1046683. PMID: 37139…

Changes in buprenorphine visits in frontier and remote locations: Effects of the SARS-CoV-2 pandemic.  McFadden LM.  Drug Alcohol Depend Rep. 2023 Jun;7:100155. doi: 10.1016/j.dadr.2023.100155. Epub 2023 Mar 29. PMID: 37065774; PMCID: PM…

Interrupted Time Series Analysis: Patient Characteristics and Rates of Opioid-Use-Disorder-Related Emergency Department Visits in the Los Angeles County Public Hospital System during COVID-19.  Johnson E, Axeen S, Vosooghi A, Lam CN, Bluthenth…

Predictors of opioid overdose during the COVID-19 pandemic: The role of relapse, treatment access and nonprescribed buprenorphine/naloxone.  Kline A, Williams JM, Steinberg ML, Mattern D, Chesin M, Borys S, Chaguturu V.  J Subst Use Addi…

Rapid adaptation during the COVID crisis: Challenges experienced in delivering service to those with Opioid Use Disorders.  Hills HA, Lengnick-Hall R, Johnson KA, Vermeer W, Hendricks Brown C, McGovern M.  Implement Res Pract. 2022 Apr 2…